892869-42-0 Usage
Uses
Used in Pharmaceutical Industry:
(3beta)-3-[[(2E)-3-(4-Chlorophenyl)-1-oxo-2-propenyl]oxy]-olean-12-en-28-oic acid is used as a pharmaceutical agent for its anti-inflammatory and anti-cancer properties. It has the potential to inhibit the growth of cancer cells and reduce inflammation, making it a promising candidate for the development of new drugs in the pharmaceutical industry.
Used in Skin Disease Treatment:
(3beta)-3-[[(2E)-3-(4-Chlorophenyl)-1-oxo-2-propenyl]oxy]-olean-12-en-28-oic acid is used as a treatment for skin diseases due to its anti-inflammatory properties. It has the potential to alleviate symptoms and improve the condition of various skin disorders.
Used in Diabetes Treatment:
(3beta)-3-[[(2E)-3-(4-Chlorophenyl)-1-oxo-2-propenyl]oxy]-olean-12-en-28-oic acid is used as a potential treatment for diabetes. Its anti-inflammatory properties may help in managing inflammation associated with diabetes and improving overall health outcomes for patients with this condition.
Check Digit Verification of cas no
The CAS Registry Mumber 892869-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,2,8,6 and 9 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 892869-42:
(8*8)+(7*9)+(6*2)+(5*8)+(4*6)+(3*9)+(2*4)+(1*2)=240
240 % 10 = 0
So 892869-42-0 is a valid CAS Registry Number.
InChI:InChI=1/C39H53ClO4/c1-34(2)20-22-39(33(42)43)23-21-37(6)27(28(39)24-34)13-14-30-36(5)18-17-31(35(3,4)29(36)16-19-38(30,37)7)44-32(41)15-10-25-8-11-26(40)12-9-25/h8-13,15,28-31H,14,16-24H2,1-7H3,(H,42,43)/b15-10+/t28-,29-,30+,31-,36-,37+,38+,39-/m0/s1
892869-42-0Relevant articles and documents
Antimycobacterial activity of cinnamate-based esters of the triterpenes betulinic, oleanolic and ursolic acids
Tanachatchairatana, Tanud,Bremner, John Barnard,Chokchaisiri, Ratchanaporn,Suksamrarn, Apichart
, p. 194 - 198 (2008/09/18)
Betulinic acid, oleanolic acid and ursolic acid have been modified at the C-3 position to cinnamate-based esters and in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Ra has been determined. The results indicated that mo
Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase
Chen, Jun,Liu, Jun,Zhang, Luyong,Wu, Guanzhong,Hua, Weiyi,Wu, Xiaoming,Sun, Hongbin
, p. 2915 - 2919 (2007/10/03)
Oleanolic acid and its synthetic derivatives have been identified as novel inhibitors of glycogen phosphorylase. Within this series of compounds, 4 (IC50 = 3.3 μM) is the most potent GPa inhibitor. Preliminary structure-activity relationships of the oleanolic acid derivatives are discussed.
